암환자가 경험하는 항암화학요법 관련 말초신경병증
The Experience of Chemotherapy-induced Peripheral Neuropathy in People with Cancer
0
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to explore the experiences of adult cancer patients living with chemotherapy induced peripheral neuropathy (CIPN). Methods: Data were collected from January 2018 to April 2018 through in-depth interviews with nine patients of colorectal and breast cancer. The main question was, ‘What is your experience living with CIPN such as tingling and/or numbness?’ . The data were analyzed using Colaizzi’s phenomenological method. Results: Three theme clusters and six themes emerged: (1) unusual body change; ‘experience of unusual distressing symptoms’ , ‘daily activities and functioning affected’ , (2) CIPN: a less important risk; ‘CIPN: a distressing and have to endure’ , ‘lack of concern and therapeutic communication’ , (3) struggle for distressing CIPN through trial and error; ‘try all the remedies that can do’ , ‘getting used to distressing CIPN’ . Conclusion: These results showed that patients did not consider CIPN important until symptoms affected daily activities and QOL. They then tried self-management strategies to deal with CIPN through trial and error. A two-way exchange of information between patients and health professionals could help patients understand CIPN and deal with symptoms if they occur.
Abstract
Purpose: The purpose of this study was to explore the experiences of adult cancer patients living with chemotherapy induced peripheral neuropathy (CIPN). Methods: Data were collected from January 2018 to April 2018 through in-depth interviews with nine patients of colorectal and breast cancer. The main question was, ‘What is your experience living with CIPN such as tingling and/or numbness?’ . The data were analyzed using Colaizzi’s phenomenological method. Results: Three theme clusters and six themes emerged: (1) unusual body change; ‘experience of unusual distressing symptoms’ , ‘daily activities and functioning affected’ , (2) CIPN: a less important risk; ‘CIPN: a distressing and have to endure’ , ‘lack of concern and therapeutic communication’ , (3) struggle for distressing CIPN through trial and error; ‘try all the remedies that can do’ , ‘getting used to distressing CIPN’ . Conclusion: These results showed that patients did not consider CIPN important until symptoms affected daily activities and QOL. They then tried self-management strategies to deal with CIPN through trial and error. A two-way exchange of information between patients and health professionals could help patients understand CIPN and deal with symptoms if they occur.
참고문헌 (24)
- Mols F, "Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry", J Cancer Surviv, 9, pp.512~522 (2015)
- Trivedi MS, "Management of chemotherapyinduced peripheral neuropathy", Am J Hematol Oncol, 11, pp.4~10 (2015)
- Park SB, "Chemotherapy-induced peripheral neurotoxicity: a critical analysis", CA Cancer J Clin, 63, pp.419~437 (2013)
- Seretny M, "Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis", Pain, 155, pp.2461~2470 (2014)
- Grenon NN, "Managing toxicities associated with colorectal cancer chemotherapy and targeted therapy: a new guide for nurses", Clin J Oncol Nurs, 13, pp.285~296 (2009)
- Velasco R, "Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients", J Neurol Neurosurg Psychiatry, 85, pp.392~398 (2014)
- Drott JE, "Oxaliplatin induced neurotoxicity among patients with colorectal cancer: documentation in medical records-a pilot study", Open J Nurs, 4, pp.265~274 (2014)
- Brami C, "Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: a systematic review", Crit Rev Oncol Hematol, 98, pp.325~334 (2016)
- Derksen TM, "Lifestyle-related factors in the self-management of chemotherapy-induced peripheral neuropathy in colorectal cancer: a systematic review", Evid Based Complement Alternat Med, 2017, pp.7916031~ (2017)
- Hershman DL, "Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline", J Clin Oncol, 32, pp.1941~1967 (2014)
- Finlay L, "Ambiguous encounters: a relational approach to phenomenological research", Indo-Pac J Phenomenol, 9, pp.1~17 (2009)
- Colaizzi PF, "Existential-phenomenological alternatives for psychology" (1978), Oxford University Press
- Sandelowski M, "The problem of rigor in qualitative research", ANS Adv Nurs Sci, 8, pp.27~37 (1986)
- Tanay MA, "The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis", Eur J Cancer Care (Engl), 26, pp.1~13 (2017)
- Tofthagen C, "Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin", Clin J Oncol Nurs, 15, pp.182~188 (2011)
- 김경연, "항암화학요법을 받는 암환자의 말초신경병증과 우울", Asian Oncology Nursing, 15(3), pp.149~155 (2015), 대한종양간호학회
- Hwang WH, "Assessment Using CIPNAT for Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy" (2013), Kosin Univ
- Attal N, "Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study", Pain, 144, pp.245~252 (2009)
- 김정혜, "항암화학요법으로 인한 말초신경병증을 경험하는 대장암 환자의 삶의 질", Asian Oncology Nursing, 11(3), pp.254~262 (2011), 대한종양간호학회
- Tofthagen C, "Patient perceptions associated with chemotherapy-induced peripheral neuropathy", Clin J Oncol Nurs, 14, pp.E22~E28 (2010)
- Speck RM, "Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients", Support Care Cancer, 20, pp.2433~2439 (2012)
- Tofthagen C, "Surviving chemotherapy for colon cancer and living with the consequences", J Palliat Med, 13, pp.1389~1391 (2010)
- 오복자, "항암화학요법관련 말초신경병증에 적용한 비약물적중재의 효과:체계적 문헌고찰 및 메타분석", Journal of Korean Academy of Nursing, 48(2), pp.123~142 (2018), 한국간호과학회
- Bennett BK, "Impact of oxaliplatin-induced neuropathy: a patient perspective", Support Care Cancer, 20, pp.2959~2967 (2012)